{"title":"治疗2型糖尿病的新药:朋友还是敌人对2型糖尿病治疗“协调”新指南的思考","authors":"José Miguel González-Clemente","doi":"10.1016/j.avdiab.2014.06.004","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.06.004","citationCount":"0","resultStr":"{\"title\":\"Nuevos fármacos para la diabetes mellitus tipo 2: amigos o enemigos. Reflexiones sobre una nueva guía de «armonización» del tratamiento de la diabetes mellitus tipo 2\",\"authors\":\"José Miguel González-Clemente\",\"doi\":\"10.1016/j.avdiab.2014.06.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100152,\"journal\":{\"name\":\"Avances en Diabetología\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.06.004\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Avances en Diabetología\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1134323014000659\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Avances en Diabetología","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1134323014000659","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Nuevos fármacos para la diabetes mellitus tipo 2: amigos o enemigos. Reflexiones sobre una nueva guía de «armonización» del tratamiento de la diabetes mellitus tipo 2